Press Release | Tissuepathology.com

DiaDeep and Leica Biosystems Partner to Bring AI Oncology Pathology Applications to the Aperio AI Store

Erica Goodpaster — Thu, 28 May 2026 14:29:19 +0000

DiaDeep and Leica Biosystems: Expanding access to integrated AI tools helps pathologists tackle complex workflows and improve insights Lyon, France and VISTA, CA — May 27, 2026 DiaDeep, a Lyon-based company specialized in medical AI for oncology pathology, and Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today […]

The post DiaDeep and Leica Biosystems Partner to Bring AI Oncology Pathology Applications to the Aperio AI Store first appeared on Tissuepathology.com.

Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026

Erica Goodpaster — Thu, 28 May 2026 14:09:25 +0000

Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Building on its deep expertise in quantitative […]

The post Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026 first appeared on Tissuepathology.com.

Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers

Erica Goodpaster — Wed, 27 May 2026 12:04:00 +0000

VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a leading provider of AI solutions for cancer diagnostics […]

The post Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers first appeared on Tissuepathology.com.

Mayo Clinic Digital Pathology building ecosystem to advance next-generation diagnostics

Erica Goodpaster — Mon, 25 May 2026 12:34:47 +0000

ROCHESTER, Minn. — Mayo Clinic Digital Pathology (MCDP) is advancing efforts to build an integrated innovation ecosystem that supports the future of pathology across clinical care and research. The work reflects Mayo Clinic’s broader digital pathology strategy, including investments in emerging companies, expanded use of digitized pathology data and collaborations designed to improve diagnostic workflows and speed. […]

The post Mayo Clinic Digital Pathology building ecosystem to advance next-generation diagnostics first appeared on Tissuepathology.com.

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Erica Goodpaster — Fri, 22 May 2026 13:53:07 +0000

CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic test will be fully integrated into the Tempus platform, providing urologists and oncologists with a digital pathology solution that helps inform personalization of therapy intensity in patients […]

The post Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use first appeared on Tissuepathology.com.

AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer

Erica Goodpaster — Tue, 19 May 2026 12:26:00 +0000

SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care across nine Asia markets, a first in the region. This landmark collaboration aims to accelerate the adoption of AI-powered digital and computational pathology through educational and training initiatives and improve […]

The post AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer first appeared on Tissuepathology.com.